Aromatase inhibitors of value in breast cancer treatment

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.319, 2001-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite

Tamoxifen Resistant and Refractory Breast Cancer: The Value of Aromatase Inhibitors

By Goss P.E.

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 957-966

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors and other novel agents in breast cancer treatment

By Saji Shigehira Toi Masakazu

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 303-319

Informa Healthcare

Access to resources Recommend Favorite

Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3476-3487

Bentham Science Publishers

Access to resources Recommend Favorite